^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Prostate Cancer
    Drug:abiraterone acetate (CYP17A1 inhibitor) +
    Vantas (histrelin acetate) (GnRH agonist)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Prostate cancer: PRINCIPLES OF ANDROGEN DEPRIVATION THERAPY...ADT for Regional (N1,M0) Disease…Options for ADT are: LHRH agonist...Goserelin, histrelin, leuprolide, or triptorelin...plus abiraterone